TheEdgeResearch
Home / Stocks / KDEVF

Karolinska Development AB (publ) (KDEVF)

OTC Healthcare Biotechnology
$0.26 ▲ +0.00%
Market Cap
$68.9M
Sector
Healthcare
Industry
Biotechnology
Beta
0.24
52-Wk Range
0.2576-0.61328
CEO
Viktor Drvota
Country
SE
Currency
USD

Karolinska Development AB (publ) operates in the Biotechnology industry of the Healthcare sector, headquartered in Solna, SE. The stock last traded at $0.26, up 0.00% on the session, giving a market capitalisation of $68.9M. On trailing twelve-month figures it carries a trailing P/E of -6.79, a net margin of -3277.0%. Its beta of 0.24 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-6.79
Price / Sales
165.06
Price / Book
0.13
EV / EBITDA
-4.31
Gross margin
82.6%
Operating margin
-3281.5%
Net margin
-3277.0%
Return on equity
—
Debt / equity
0.00
Current ratio
128.29
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
8
IPO date
2019-04-05
Headquarters
Solna, SE
About Karolinska Development AB (publ)

KDventures AB is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. The company was formerly known as Karolinska Development AB (publ) and change its name to KDventures AB in February 2026. KDventures AB was founded in 2003 and is headquartered in Solna, Sweden.

Comparable companies

Karolinska Development AB (publ) is most often compared with the following Healthcare names:

BSTGEOFBYETXPFHRPMFKIARFMSSTFMVRBFNEVPFONPPFSYMQY
More research on KDEVF
KDEVF technical analysis KDEVF TheEdge Score Compare against peers
Open full interactive analysis & DCF →